(Amounts in millions)

Consolidated Statements of Income Information

Revenues:

Premiums

Net investment income

Net investment gains (losses) ⁽¹⁾

Insurance and investment product fees and other

Total revenues

Benefits and expenses:

Benefits and operating expenses

Interest expense

Total benefits and expenses

Income (loss) from continuing operations before income taxes

Provision (benefit) for income taxes

Income (loss) from continuing operations

Income from discontinued operations, net of taxes ⁽²⁾

Gain on sale of discontinued operations, net of taxes ⁽²⁾

Net income (loss)

Less: net income attributable to noncontrolling interests ⁽³⁾

Net income (loss) available to Genworth Financial, Inc.’s common stockholders

Income (loss) from continuing operations per common share:

Basic

Diluted ⁽⁴⁾

Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share:

Basic

Diluted ⁽⁴⁾

Weighted-average common shares outstanding: ⁽⁵⁾

Basic

Diluted ⁽⁴⁾

Cash dividends declared per common share ⁽⁶⁾

(Amounts in millions)

Selected Segment Information

Total revenues:

U.S. Life Insurance

International Protection

Wealth Management

International Mortgage Insurance

U.S. Mortgage Insurance

Runoff

Corporate and Other

Total

Income (loss) from continuing operations:

U.S. Life Insurance

International Protection

Wealth Management

International Mortgage Insurance

U.S. Mortgage Insurance

Runoff

Corporate and Other

Total

Consolidated Balance Sheet Information

Total investments

All other assets ⁽⁷⁾

Total assets

Policyholder liabilities

Non-recourse funding obligations

Short-term borrowings

Long-term borrowings

All other liabilities

Total liabilities

Accumulated other comprehensive income (loss)

Noncontrolling interests ⁽³⁾

Total stockholders’ equity

U.S. Statutory Financial Information ⁽⁸⁾

Statutory capital and surplus ⁽⁹⁾

Asset valuation reserve

On April 1, 2009, we adopted new accounting guidance related to the recognition and presentation of other-than-temporary impairments. This accounting guidance modified the presentation of other-than-temporary impairments for certain debt securities to only present the impairment loss in net income (loss) that represents the credit loss associated with the other-than-temporary impairment with the remaining impairment loss being presented in other comprehensive income (loss). For further discussion, refer to note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” included in Exhibit 99.5.

On May 31, 2007, we completed the sale of our group life and health insurance business. Accordingly, the business was accounted for as discontinued operations and its results of operations, financial position and cash flows were separately reported for all periods presented. The sale resulted in a gain on sale of discontinued operations of $51 million, net of taxes.

Noncontrolling interests relate to the initial public offering of our Canadian mortgage insurance business in July 2009 which reduced our ownership percentage to 57.5%.

Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for December 31, 2009 and 2008, the inclusion of 1.9 million and 1.7 million, respectively, of shares for stock options, restricted stock units (“RSUs”) and stock appreciation rights (“SARs”) would have been antidilutive to the calculation. If we had not incurred a net loss for 2009 and 2008, dilutive potential common shares would have been 453.0 million and 434.9 million, respectively.

The number of shares used in our calculation of diluted earnings per common share in 2007, 2008, 2009, 2010 and 2011 was affected by the additional shares of Class A Common Stock issuable under Equity Units, stock options, RSUs and SARs and was calculated using the treasury method. In May 2009, stockholders approved, and in July 2009 we commenced, an offer to eligible employees to exchange eligible stock options and SARs (the “Eligible Options and SARs”) for a reduced number of stock options and SARs (collectively, the “Replacement Awards”). In August 2009, we granted the Replacement Awards, consisting of an aggregate of 2.6 million new stock options and 308,210 new SARs, in exchange for the Eligible Options and SARs surrendered in the exchange offer. Weighted-average shares outstanding also increased reflecting a public offering of 55.2 million shares of our Class A Common Stock in September 2009. See note 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” included in Exhibit 99.5 for a discussion of the exchange offer completed in August 2009 and note 3 for a discussion of the equity offering in September 2009.

During the first and second quarters of 2007, we declared dividends of $0.09 per common share. During the third quarter of 2007, we increased the quarterly dividend 11% and declared dividends of $0.10 per common share in the third and fourth quarters of 2007 and the first, second and third quarters of 2008. In November 2008, to enhance our liquidity and capital position in the challenging market environment, our Board of Directors suspended the payment of dividends on our common stock indefinitely. Therefore, no dividends were declared in the fourth quarter of 2008 or in 2009, 2010 and 2011.

Prior to the completion of our IPO, we entered into several significant reinsurance transactions with UFLIC, an affiliate of our former parent, in which we ceded certain blocks of structured settlement annuities, variable annuities and long-term care insurance. As a result of these transactions, we transferred investment securities to UFLIC and recorded a reinsurance recoverable that was included in “all other assets.” For a discussion of this transaction, refer to note 9 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” included in Exhibit 99.5.

We derived the U.S. Statutory Financial Information from Annual Statements of our U.S. insurance company subsidiaries that were filed with the insurance departments in states where we are domiciled and were prepared in accordance with statutory accounting practices prescribed or permitted by the insurance departments in states where we are domiciled. These statutory accounting practices vary in certain material respects from U.S. GAAP.

Combined statutory capital and surplus for our U.S. domiciled insurance subsidiaries includes surplus notes issued by our U.S. life insurance subsidiaries and statutorily required contingency reserves held by our U.S. mortgage insurance subsidiaries.